{"date":"2025-06-19","count":35,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6879-2025-06-19-1850-qflmkr","company_id":"6879","company":"大江基因","market":"興櫃","industry":"生技醫療","date":"2025-06-19","time":"18:50:16","subject":"公告本公司董事會通過委任風險管理委員會委員","clause":"第6款","fact_date":"2025-06-19","cite_as":"公開資訊觀測站重大訊息：大江基因（6879），2025-06-19 18:50，「公告本公司董事會通過委任風險管理委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6879-2025-06-19-1849-1skn09x","company_id":"6879","company":"大江基因","market":"興櫃","industry":"生技醫療","date":"2025-06-19","time":"18:49:25","subject":"公告本公司董事會通過委任提名委員會委員","clause":"第6款","fact_date":"2025-06-19","cite_as":"公開資訊觀測站重大訊息：大江基因（6879），2025-06-19 18:49，「公告本公司董事會通過委任提名委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6879-2025-06-19-1848-1mve6xu","company_id":"6879","company":"大江基因","market":"興櫃","industry":"生技醫療","date":"2025-06-19","time":"18:48:39","subject":"公告本公司董事會通過委任薪資報酬委員會委員","clause":"第6款","fact_date":"2025-06-19","cite_as":"公開資訊觀測站重大訊息：大江基因（6879），2025-06-19 18:48，「公告本公司董事會通過委任薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6879-2025-06-19-1847-13sk2v0","company_id":"6879","company":"大江基因","market":"興櫃","industry":"生技醫療","date":"2025-06-19","time":"18:47:57","subject":"公告本公司審計委員會委員異動","clause":"第6款","fact_date":"2025-06-19","cite_as":"公開資訊觀測站重大訊息：大江基因（6879），2025-06-19 18:47，「公告本公司審計委員會委員異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6879-2025-06-19-1847-9769qc","company_id":"6879","company":"大江基因","market":"興櫃","industry":"生技醫療","date":"2025-06-19","time":"18:47:14","subject":"公告本公司董事會選任董事長","clause":"第6款","fact_date":"2025-06-19","cite_as":"公開資訊觀測站重大訊息：大江基因（6879），2025-06-19 18:47，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6879-2025-06-19-1846-rogi2n","company_id":"6879","company":"大江基因","market":"興櫃","industry":"生技醫療","date":"2025-06-19","time":"18:46:32","subject":"公告本公司2025年股東常會通過解除新任董事及其代表人競業禁止之限制案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大江基因（6879），2025-06-19 18:46，「公告本公司2025年股東常會通過解除新任董事及其代表人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6879-2025-06-19-1845-se1izt","company_id":"6879","company":"大江基因","market":"興櫃","industry":"生技醫療","date":"2025-06-19","time":"18:45:26","subject":"公告本公司2025年股東常會全面改選董事及獨立董事","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大江基因（6879），2025-06-19 18:45，「公告本公司2025年股東常會全面改選董事及獨立董事」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6879-2025-06-19-1844-cc5145","company_id":"6879","company":"大江基因","market":"興櫃","industry":"生技醫療","date":"2025-06-19","time":"18:44:05","subject":"公告本公司2025年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大江基因（6879），2025-06-19 18:44，「公告本公司2025年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6572-2025-06-19-1842-9769qc","company_id":"6572","company":"博錸","market":"興櫃","industry":"生技醫療","date":"2025-06-19","time":"18:42:25","subject":"公告本公司董事會選任董事長","clause":"第6款","fact_date":"2025-06-19","cite_as":"公開資訊觀測站重大訊息：博錸（6572），2025-06-19 18:42，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6572-2025-06-19-1841-nf5tqo","company_id":"6572","company":"博錸","market":"興櫃","industry":"生技醫療","date":"2025-06-19","time":"18:41:53","subject":"公告本公司114年股東常會全面改選董事當選名單","clause":"第6款","fact_date":"2025-06-19","cite_as":"公開資訊觀測站重大訊息：博錸（6572），2025-06-19 18:41，「公告本公司114年股東常會全面改選董事當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6572-2025-06-19-1841-1cugv11","company_id":"6572","company":"博錸","market":"興櫃","industry":"生技醫療","date":"2025-06-19","time":"18:41:26","subject":"公告本公司114年股東常會通過解除本公司董事及其代表人競業禁止之限制案","clause":"第22款","fact_date":"2025-06-19","cite_as":"公開資訊觀測站重大訊息：博錸（6572），2025-06-19 18:41，「公告本公司114年股東常會通過解除本公司董事及其代表人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6572-2025-06-19-1841-27irsl","company_id":"6572","company":"博錸","market":"興櫃","industry":"生技醫療","date":"2025-06-19","time":"18:41:02","subject":"公告本公司第三屆薪資報酬委員會委員任期屆滿及新任薪資報酬委員名單","clause":"第6款","fact_date":"2025-06-19","cite_as":"公開資訊觀測站重大訊息：博錸（6572），2025-06-19 18:41，「公告本公司第三屆薪資報酬委員會委員任期屆滿及新任薪資報酬委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6572-2025-06-19-1840-hiebb2","company_id":"6572","company":"博錸","market":"興櫃","industry":"生技醫療","date":"2025-06-19","time":"18:40:35","subject":"公告本公司114年股東會重要決議事項","clause":"第15款","fact_date":"2025-06-19","cite_as":"公開資訊觀測站重大訊息：博錸（6572），2025-06-19 18:40，「公告本公司114年股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6572-2025-06-19-1838-1kd6mdc","company_id":"6572","company":"博錸","market":"興櫃","industry":"生技醫療","date":"2025-06-19","time":"18:38:55","subject":"公告本公司審計委員會委員任期屆滿及新任審計委員名單","clause":"第6款","fact_date":"2025-06-19","cite_as":"公開資訊觀測站重大訊息：博錸（6572），2025-06-19 18:38，「公告本公司審計委員會委員任期屆滿及新任審計委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1734-2025-06-19-1718-1qy8448","company_id":"1734","company":"杏輝","market":"上市","industry":"生技醫療","date":"2025-06-19","time":"17:18:23","subject":"代重要子公司SUNETIC BIOTECH INC.公告股東常會重要決議事項","clause":"第18款","fact_date":"2025-06-19","cite_as":"公開資訊觀測站重大訊息：杏輝（1734），2025-06-19 17:18，「代重要子公司SUNETIC BIOTECH INC.公告股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1734-2025-06-19-1718-iik2fr","company_id":"1734","company":"杏輝","market":"上市","industry":"生技醫療","date":"2025-06-19","time":"17:18:11","subject":"代重要子公司SUNETIC BIOTECH INC.公告董事會公告決議股利分派事宜","clause":"第14款","fact_date":"2025-06-19","cite_as":"公開資訊觀測站重大訊息：杏輝（1734），2025-06-19 17:18，「代重要子公司SUNETIC BIOTECH INC.公告董事會公告決議股利分派事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1734-2025-06-19-1717-1byfckg","company_id":"1734","company":"杏輝","market":"上市","industry":"生技醫療","date":"2025-06-19","time":"17:17:56","subject":"代重要子公司杏輝天力(杭州)藥業有限公司公告決議股利分派事宜","clause":"第14款","fact_date":"2025-06-19","cite_as":"公開資訊觀測站重大訊息：杏輝（1734），2025-06-19 17:17，「代重要子公司杏輝天力(杭州)藥業有限公司公告決議股利分派事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1734-2025-06-19-1716-2hh8jm","company_id":"1734","company":"杏輝","market":"上市","industry":"生技醫療","date":"2025-06-19","time":"17:16:29","subject":"公告本公司董事會決議除息基準日等事宜","clause":"第14款","fact_date":"2025-06-19","cite_as":"公開資訊觀測站重大訊息：杏輝（1734），2025-06-19 17:16，「公告本公司董事會決議除息基準日等事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1734-2025-06-19-1716-na4vgy","company_id":"1734","company":"杏輝","market":"上市","industry":"生技醫療","date":"2025-06-19","time":"17:16:11","subject":"公告本公司股東常會重要決議事項","clause":"第18款","fact_date":"2025-06-19","cite_as":"公開資訊觀測站重大訊息：杏輝（1734），2025-06-19 17:16，「公告本公司股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6662-2025-06-19-1657-tc88vo","company_id":"6662","company":"樂斯科","market":"上櫃","industry":"生技醫療","date":"2025-06-19","time":"16:57:44","subject":"公告本公司新任審計委員會委員","clause":"第6款","fact_date":"2025-06-19","cite_as":"公開資訊觀測站重大訊息：樂斯科（6662），2025-06-19 16:57，「公告本公司新任審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4173-2025-06-19-1652-18i608t","company_id":"4173","company":"久裕","market":"上櫃","industry":"生技醫療","date":"2025-06-19","time":"16:52:13","subject":"公告本公司一一四年股東常會通過解除部份董事競業禁止","clause":"第21款","fact_date":"2025-06-19","cite_as":"公開資訊觀測站重大訊息：久裕（4173），2025-06-19 16:52，「公告本公司一一四年股東常會通過解除部份董事競業禁止」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4173-2025-06-19-1649-8gn1d","company_id":"4173","company":"久裕","market":"上櫃","industry":"生技醫療","date":"2025-06-19","time":"16:49:41","subject":"公告本公司一一四年股東常會重要決議事項","clause":"第18款","fact_date":"2025-06-19","cite_as":"公開資訊觀測站重大訊息：久裕（4173），2025-06-19 16:49，「公告本公司一一四年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6662-2025-06-19-1649-8y7k8e","company_id":"6662","company":"樂斯科","market":"上櫃","industry":"生技醫療","date":"2025-06-19","time":"16:49:19","subject":"公告本公司114年股東常會補選獨立董事當選名單","clause":"第6款","fact_date":"2025-06-19","cite_as":"公開資訊觀測站重大訊息：樂斯科（6662），2025-06-19 16:49，「公告本公司114年股東常會補選獨立董事當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2025-06-19-1641-1n4thqi","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2025-06-19","time":"16:41:04","subject":"公告本公司訂定現金股利除息基準日等相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2025-06-19 16:41，「公告本公司訂定現金股利除息基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2025-06-19-1636-11ck10j","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2025-06-19","time":"16:36:21","subject":"公告本公司新任會計主管","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2025-06-19 16:36，「公告本公司新任會計主管」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2025-06-19-1635-1asmasq","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2025-06-19","time":"16:35:36","subject":"本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2025-06-19 16:35，「本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6662-2025-06-19-1628-ds864w","company_id":"6662","company":"樂斯科","market":"上櫃","industry":"生技醫療","date":"2025-06-19","time":"16:28:26","subject":"公告本公司114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-06-19","cite_as":"公開資訊觀測站重大訊息：樂斯科（6662），2025-06-19 16:28，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2025-06-19-1559-1kj3cgm","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2025-06-19","time":"15:59:25","subject":"公告本公司薪資報酬委員會名單","clause":"第6款","fact_date":"2025-06-19","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2025-06-19 15:59，「公告本公司薪資報酬委員會名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2025-06-19-1558-p3pl10","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2025-06-19","time":"15:58:41","subject":"公告本公司審計委員會委員名單","clause":"第6款","fact_date":"2025-06-19","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2025-06-19 15:58，「公告本公司審計委員會委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2025-06-19-1557-1dhzh9t","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2025-06-19","time":"15:57:34","subject":"公告本公司114年股東常會通過解除新任董事競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2025-06-19 15:57，「公告本公司114年股東常會通過解除新任董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-06-19-1552-ds864w","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-06-19","time":"15:52:19","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-06-19 15:52，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2025-06-19-1550-7hfo9v","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2025-06-19","time":"15:50:25","subject":"公告本公司董事會推舉董事長及副董事長相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2025-06-19 15:50，「公告本公司董事會推舉董事長及副董事長相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2025-06-19-1547-19o1zaj","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2025-06-19","time":"15:47:32","subject":"公告本公司114年股東常會全面改選董事之當選名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2025-06-19 15:47，「公告本公司114年股東常會全面改選董事之當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2025-06-19-1537-wxca8k","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2025-06-19","time":"15:37:28","subject":"114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2025-06-19 15:37，「114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-06-19-1434-zv6htc","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-06-19","time":"14:34:41","subject":"本公司授權夥伴Sandoz提出生物相似藥EG12014 (Trastuzumab Biosimilar) 150毫克凍晶注射劑向美國FDA遞交藥證申覆審查","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-06-19 14:34，「本公司授權夥伴Sandoz提出生物相似藥EG12014 (Trastuzumab Biosimilar) 150毫克凍晶」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}